HC Wainwright & Co. reiterated coverage on Salarius Pharmaceuticals with a new price target

3/11/22 6:32:47 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

HC Wainwright & Co. reiterated coverage of Salarius Pharmaceuticals with a rating of Buy and set a new price target of $4.00 from $5.00 previously

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$SLRX

Date	Price Target	Rating	Analyst
3/11/2022	$5.00 → $4.00	Buy	HC Wainwright & Co.
8/25/2021	$5.00	Buy	HC Wainwright & Co.